Diebold Nixdorf - DBD Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" DBD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DBD, but not buy additional shares or sell existing shares.
View DBD analyst ratings or view top-rated stocks.

3 analysts have issued 12 month target prices for Diebold Nixdorf's shares. Their DBD share price forecasts range from $3.00 to $5.00. On average, they expect the company's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 60.6% from the stock's current price.
View analysts price targets for DBD or view top-rated stocks among Wall Street analysts.

Diebold Nixdorf's stock was trading at $1.42 at the start of the year. Since then, DBD stock has increased by 75.4% and is now trading at $2.49.
View the best growth stocks for 2023 here.

Diebold Nixdorf saw a decline in short interest during the month of December. As of December 30th, there was short interest totaling 9,860,000 shares, a decline of 8.9% from the December 15th total of 10,820,000 shares. Based on an average daily trading volume, of 1,820,000 shares, the short-interest ratio is currently 5.4 days. Currently, 13.2% of the company's shares are short sold.
View Diebold Nixdorf's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our DBD earnings forecast.

Diebold Nixdorf will be holding an earnings conference call on Thursday, February 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Diebold Nixdorf, Incorporated (NYSE:DBD) announced its earnings results on Tuesday, November, 8th. The technology company reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.28 by $0.39. The technology company earned $810.40 million during the quarter, compared to analysts' expectations of $836.29 million.

Diebold Nixdorf updated its FY 2023 earnings guidance on Saturday, December, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.86 billion-$3.86 billion, compared to the consensus revenue estimate of $3.72 billion.

175 employees have rated Diebold Nixdorf Chief Executive Officer Gerrard B. Schmid on Glassdoor.com. Gerrard B. Schmid has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co. Inc. (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin' Brands Group (DNKN).

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Diebold Nixdorf's stock is owned by a variety of institutional and retail investors. Top institutional investors include Beach Point Capital Management LP (3.66%), Bank of Montreal Can (0.57%), Strs Ohio (0.31%), Arlington Partners LLC (0.16%), Rothschild Investment Corp IL (0.06%) and Merit Financial Group LLC (0.06%). Insiders that own company stock include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Jonathan Leiken, Lauren States, Matthew Goldfarb, Octavio Marquez, Olaf Robert Heyden and Phillip R Cox.
View institutional ownership trends.

Shares of DBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DBD stock can currently be purchased for approximately $2.49.

Diebold Nixdorf (NYSE:DBD) has a market capitalization of $196.91 million and generates $3.91 billion in revenue each year. The technology company earns $-78,800,000.00 in net income (profit) each year or ($5.97) on an earnings per share basis.

The company employs 22,000 workers across the globe.

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The official website for the company is www.dieboldnixdorf.com. The technology company can be reached via phone at (330) 490-4000, via email at steve.virostek@dieboldnixdorf.com, or via fax at 330-490-3794.